Endoceuticals, engineered for commercial scale
Pelagic discovers, develops and commercialises bioactive molecules rooted in human biology. We combine human data, synthetic biology, precision fermentation and advanced lipid science to create precisely defined ingredients and finished products.
From human biology to real products
Pelagic is an industrial biotechnology company translating endogenous biology into scalable health products. Our activities span product development, synthetic biology, precision fermentation, advanced lipid science, regulatory planning, research coordination and commercial partnerships.
Through Pelagic Italia, we are developing an integrated European platform for R&D, scale-up and advanced manufacturing in Campania.
Our Portfolio
-
Sprevive®
Learn More About Sprevive®High-purity spermidine produced through precision fermentation. A commercial platform for premium health products and selected partner applications.
-
Etheriol™
Learn More About Etheriol™A non-animal-derived LPE(O) ether lipid designed to provide a precise route into plasmalogen biology. Available for research and commercial evaluation.
-
Neurisy™
Learn More About Neurisy™A next-generation LPC(O) ether-lipid programme for future brain-health applications. Currently in development.
What is an endoceutical?
Endoceutical is Pelagic’s term for a bioactive molecule naturally present in human biology, or a closely related precursor the body can use. We identify promising molecules from human data, create a reproducible production route, validate them scientifically and translate them into ingredients and finished products.
From discovery to market
Step 1: Discover
Human data, metabolomics and causal analysis identify promising endogenous bioactives.
Step 2: Design
We select the optimal molecule, precursor, format and production route.
Step 3: Produce
Synthetic biology, precision fermentation and advanced chemistry create
consistent supply.
Step 4: Validate
Analytical, safety and human research establish identity, quality and
evidence.
Step 5: Commercialise
Pelagic brings products to market directly and through selected partners.
Making scarce biology scalable
Many valuable biomolecules occur at low concentrations in nature or are difficult to isolate consistently. Pelagic uses synthetic biology and precision fermentation alongside process chemistry, purification and analytical quality control to create defined, reproducible supply. Sprevive provides a commercial example of this approach; Etheriol extends it to advanced ether lipids.
Building in Italy
Pelagic Italia is Pelagic’s European operating platform for product development, commercialisation and industrial scale-up. Its planned Campania investment will integrate advanced R&D, pilot and process-development capability, analytical quality systems and commercial manufacturing.
The programme is designed to create skilled employment, strengthen European biotechnology capacity and support the production and export of high-value health ingredients.